JP2004131388A - Skin care preparation for external use - Google Patents
Skin care preparation for external use Download PDFInfo
- Publication number
- JP2004131388A JP2004131388A JP2002294467A JP2002294467A JP2004131388A JP 2004131388 A JP2004131388 A JP 2004131388A JP 2002294467 A JP2002294467 A JP 2002294467A JP 2002294467 A JP2002294467 A JP 2002294467A JP 2004131388 A JP2004131388 A JP 2004131388A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- cooling
- hydroquinone
- whitening
- mask
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims abstract description 71
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 34
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- -1 hydroquinone glycoside Chemical class 0.000 claims abstract description 17
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims abstract description 16
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 12
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims abstract description 11
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 11
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 11
- 229930182470 glycoside Natural products 0.000 claims abstract description 9
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 8
- 239000002211 L-ascorbic acid Substances 0.000 claims abstract description 7
- 235000000069 L-ascorbic acid Nutrition 0.000 claims abstract description 7
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims abstract description 4
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims abstract description 4
- 229920002079 Ellagic acid Polymers 0.000 claims abstract description 4
- 108010024636 Glutathione Proteins 0.000 claims abstract description 4
- 229960002852 ellagic acid Drugs 0.000 claims abstract description 4
- 235000004132 ellagic acid Nutrition 0.000 claims abstract description 4
- 229960003180 glutathione Drugs 0.000 claims abstract description 4
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960004705 kojic acid Drugs 0.000 claims abstract description 4
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 4
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000002087 whitening effect Effects 0.000 claims description 67
- 239000002537 cosmetic Substances 0.000 claims description 14
- 239000004745 nonwoven fabric Substances 0.000 claims description 12
- 229940051879 analgesics and antipyretics salicylic acid and derivative Drugs 0.000 claims 1
- 238000001816 cooling Methods 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 16
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract description 10
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract description 5
- 229960004889 salicylic acid Drugs 0.000 abstract description 5
- 239000007844 bleaching agent Substances 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 238000004061 bleaching Methods 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 37
- 230000035597 cooling sensation Effects 0.000 description 27
- 238000011156 evaluation Methods 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 150000003839 salts Chemical class 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000006210 lotion Substances 0.000 description 12
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical class CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 230000035807 sensation Effects 0.000 description 8
- 229930182478 glucoside Natural products 0.000 description 7
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000002826 coolant Substances 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 229960001755 resorcinol Drugs 0.000 description 4
- RJURRZFUWSRXDY-UHFFFAOYSA-N 1-phenoxyethanol Chemical compound CC(O)OC1=CC=CC=C1.CC(O)OC1=CC=CC=C1 RJURRZFUWSRXDY-UHFFFAOYSA-N 0.000 description 3
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000011777 magnesium Chemical class 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011591 potassium Chemical class 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- MDVYIGJINBYKOM-IBSWDFHHSA-N 3-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxypropane-1,2-diol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCC(O)CO MDVYIGJINBYKOM-IBSWDFHHSA-N 0.000 description 2
- AUZQQIPZESHNMG-UHFFFAOYSA-N 3-methoxysalicylic acid Chemical compound COC1=CC=CC(C(O)=O)=C1O AUZQQIPZESHNMG-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- SRBFZHDQGSBBOR-KLVWXMOXSA-N beta-L-arabinopyranose Chemical compound O[C@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-KLVWXMOXSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- MSWZFWKMSRAUBD-GKFJPSPNSA-N (2r,3s,4s,5r,6s)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol Chemical compound N[C@@H]1[C@H](O)O[C@@H](CO)[C@H](O)[C@H]1O MSWZFWKMSRAUBD-GKFJPSPNSA-N 0.000 description 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-VFUOTHLCSA-N 2-amino-2-deoxy-beta-D-galactopyranose Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-VFUOTHLCSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- JBRMEFWJFBHUKG-UHFFFAOYSA-N 4-[(diaminomethylideneamino)methyl]cyclohexane-1-carboxylic acid Chemical compound NC(N)=NCC1CCC(C(O)=O)CC1 JBRMEFWJFBHUKG-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- 229930188104 Alkylresorcinol Natural products 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- AVWTXYWHGFHGQD-ZKCHVHJHSA-N CNC(=O)[C@H]1CC[C@H](CN)CC1 Chemical compound CNC(=O)[C@H]1CC[C@H](CN)CC1 AVWTXYWHGFHGQD-ZKCHVHJHSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000220156 Saxifraga Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- SRBFZHDQGSBBOR-MBMOQRBOSA-N alpha-D-arabinopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-MBMOQRBOSA-N 0.000 description 1
- MSWZFWKMSRAUBD-DVKNGEFBSA-N alpha-D-galactosamine Chemical compound N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-DVKNGEFBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- GZCGUPFRVQAUEE-UHFFFAOYSA-N alpha-D-galactose Natural products OCC(O)C(O)C(O)C(O)C=O GZCGUPFRVQAUEE-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- HMFHBZSHGGEWLO-AIHAYLRMSA-N alpha-D-ribose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-AIHAYLRMSA-N 0.000 description 1
- WQZGKKKJIJFFOK-SXUWKVJYSA-N alpha-L-galactose Chemical compound OC[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-SXUWKVJYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-ORELYVPDSA-N alpha-L-glucopyranuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-ORELYVPDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-MDMQIMBFSA-N alpha-L-glucose Chemical compound OC[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-MDMQIMBFSA-N 0.000 description 1
- HMFHBZSHGGEWLO-NEEWWZBLSA-N alpha-L-ribose Chemical compound OC[C@@H]1O[C@@H](O)[C@@H](O)[C@H]1O HMFHBZSHGGEWLO-NEEWWZBLSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-YDMGZANHSA-N beta-D-Glucosamine Natural products N[C@H]1[C@H](O)O[C@@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-YDMGZANHSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SQOUGZDYSA-N beta-D-arabinopyranose Chemical compound O[C@@H]1CO[C@@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-SQOUGZDYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- HMFHBZSHGGEWLO-TXICZTDVSA-N beta-D-ribose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-TXICZTDVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-KGJVWPDLSA-N beta-L-galactose Chemical compound OC[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-KGJVWPDLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QYESYBIKSA-N beta-L-glucose Chemical compound OC[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-QYESYBIKSA-N 0.000 description 1
- HMFHBZSHGGEWLO-FCAWWPLPSA-N beta-L-ribose Chemical compound OC[C@@H]1O[C@H](O)[C@@H](O)[C@H]1O HMFHBZSHGGEWLO-FCAWWPLPSA-N 0.000 description 1
- 229940017687 beta-d-ribose Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- USAIOOFEIMNEDN-UHFFFAOYSA-L disodium;carbonotrithioate Chemical compound [Na+].[Na+].[S-]C([S-])=S USAIOOFEIMNEDN-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940041290 mannose Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は皮膚外用剤に関する。さらに詳しくは、冷却感を飛躍的に高め、かつその効果を持続させることができるとともに、薬剤(美白剤)の浸透感、美白効果感、潤い感に極めて優れた効果を有する皮膚外用剤に関する。本発明は特に不織布含浸化粧料(マスク)として好適に用いられる。
【0002】
【従来の技術】
皮膚外用剤においては、清涼感の遅効性を有するメントール誘導体(乳酸メンチル、メントキシプロパンジオール、メンチルグルコシドなど)を配合して、清涼感の持続を図ったものが提供されている。しかし、メントール誘導体は、清涼感効果という点ではメントール、カンファー等の従来からの清涼剤に比べると乏しく、そのためこれら従来からの清涼剤と併用したり、低級アルコールやシリコーンオイルと併用する等の手段によって、清涼感およびその持続感を図っている(例えば特許文献1参照)。
【0003】
このようにメントール誘導体を配合した皮膚外用剤は種々提案されているが、従来のものはいずれも、メントール誘導体による清涼感の持続性という概念の域を出るものではなかった。
【0004】
【特許文献1】
特開2001−226252号公報
【0005】
【発明が解決しようとする課題】
本発明は、飛躍的に冷却感を高め、しかもその冷却感が持続し、かつ美白薬剤の浸透感、美白効果感等を飛躍的に高めた皮膚外用剤を提供することを目的とする。
【0006】
【課題を解決するための手段】
上記課題を解決するための本発明は、乳酸メンチルを0.0001〜0.10質量%と、美白剤を含有する、皮膚外用剤を提供する。
【0007】
また本発明は、美白剤が、ハイドロキノン配糖体およびその誘導体、L−アスコルビン酸およびその誘導体、トラネキサム酸およびその誘導体、サリチル酸およびその誘導体、レゾルシンおよびその誘導体、グルタチオン、コウジ酸、エラグ酸の中から選ばれる1種または2種以上である、上記皮膚外用剤を提供する。
【0008】
また本発明は、不織布含浸化粧料(マスク)である、上記皮膚外用剤を提供する。
【0009】
【発明の実施の形態】
以下、本発明を詳細に説明する。
【0010】
本発明で用いられる乳酸メンチルは、メントール誘導体の1種で、遅効性清涼剤として既知である。例えば化粧水などの処方において、メントール誘導体を配合することにより清涼感の持続性をもたせることが知られている。しかしながら、メントール誘導体の中でも特に乳酸メンチルを選択し、この乳酸メンチルと美白剤とを組合せ配合することで、冷却感を飛躍的に高めることができるとともに、美白剤の浸透感、美白効果感も飛躍的に高めることができるという知見は、今回、本発明者らによって初めて見出されたものであり、本願発明に特有の効果である。
【0011】
清涼感・冷却感と、炎症抑制作用との関連性については、既存技術として一般的に知られているが、冷却感と美白効果感、美白浸透感の因果関係については、その効果の確認すらされていず、全く知見が得られていなかった。
【0012】
とりわけ本願発明を不織布含浸化粧料(マスク)として用いた場合、マスクは、その製品の特性上、化粧料の中でも特に、「剥がした後、肌が白くなって透明感が高くなった効果感を有する」という実効感が高く評価される傾向にあることから、本願発明により得られる上記効果は極めて優れるものである。
【0013】
特に化粧水、美容液等の水系化粧料では、その気化熱により冷却感を感じるようになっている。このようなこのような化粧水、美容液等の水系化粧料を不織布に含浸したマスクとして用いた場合、マスクを肌に貼付している間、冷却感による心地よさを感じる長所があったが、これまでマスクは貼付時の気化熱による心地よい感じを特長とするのみに止まっていた。本願発明により、気化熱による冷却感に止まらず、飛躍的に冷却感を高め、しかもその冷却感が持続し、かつ美白薬剤の浸透感、美白効果感等を飛躍的に高めた皮膚外用剤が得ることができた。
【0014】
このような本願発明効果を奏するには、乳酸メンチルは本発明皮膚外用剤全量中に0.0001〜0.10質量%配合する必要があり、好ましくは0.0005〜0.10質量%である。0.0001質量%未満では十分な冷却感を感じることができず、一方、0.10質量%超では美白剤の浸透感、美白効果感が下がる傾向がみられる。
【0015】
上記乳酸メンチルと組み合せて用いる美白剤としては、一般に化粧料に用いられ得る美白剤であれば特に限定されるものでないが、本発明ではハイドロキノン配糖体およびその誘導体、L−アスコルビン酸およびその誘導体、トラネキサム酸およびその誘導体、サリチル酸およびその誘導体、レゾルシンおよびその誘導体、グルタチオン、コウジ酸、エラグ酸等が好ましく用いられる。
【0016】
ハイドロキノン配糖体としては、例えばハイドロキノンα−D−グルコース、ハイドロキノンβ−D−グルコース(「アルブチン」ともいう)、ハイドロキノンα−L−グルコース、ハイドロキノンβ−L−グルコース、ハイドロキノンα−D−ガラクトース、ハイドロキノンβ−D−ガラクトース、ハイドロキノンα−L−ガラクトース、ハイドロキノンβ−L−ガラクトース等の六炭糖配糖体;ハイドロキノンα−D−リボース、ハイドロキノンβ−D−リボース、ハイドロキノンα−L−リボース、ハイドロキノンβ−L−リボース、ハイドロキノンα−D−アラビノース、ハイドロキノンβ−D−アラビノース、ハイドロキノンα−L−アラビノース、ハイドロキノンβ−L−アラビノース等の五炭糖配糖体;ハイドロキノンα−D−グルコサミン、ハイドロキノンβ−D−グルコサミン、ハイドロキノンα−L−グルコサミン、ハイドロキノンβ−L−グルコサミン、ハイドロキノンα−D−ガラクトサミン、ハイドロキノンβ−D−ガラクトサミン、ハイドロキノンα−L−ガラクトサミン、ハイドロキノンβ−L−ガラクトサミン等のアミノ糖配糖体;ハイドロキノンα−D−グルクロン酸、ハイドロキノンβ−D−グルクロン酸、ハイドロキノンα−L−グルクロン酸、ハイドロキノンβ−L−グルクロン酸、ハイドロキノンα−D−ガラクツロン酸、ハイドロキノンβ−D−ガラクツロン酸、ハイドロキノンα−L−ガラクツロン酸、ハイドロキノンβ−L−ガラクツロン酸等のウロン酸炭糖配糖体などが例示される。またその誘導体としては、アセチル化物等のエステル体、メチル化物等のエステル体などが挙げられる。中でも美白効果、入手の容易性、安定性等の面からアスコルビン酸グルコシドが好ましい。
【0017】
L−アスコルビン酸は、一般にビタミンCといわれ、その強い還元作用により細胞呼吸作用、酵素賦活作用、膠原形成作用を有し、かつメラニン還元作用を有する。L−アスコルビン酸誘導体としては、例えばL−アスコルビン酸モノリン酸エステル、L−アスコルビン酸2−硫酸エステルなどのL−アスコルビン酸モノエステル類や、L−アスコルビン酸2−グルコシドなどのL−アスコルビン酸グルコシド類、あるいはこれらの塩などが挙げられるが、これら例示に限定されるものでない。塩としてはナトリウム、カリウム、マグネシウム、トリエタノールアミンなどの各塩が例示される。
【0018】
トラネキサム酸およびその誘導体としては、トラネキサム酸、トラネキサム酸の二量体〔例えば、塩酸トランス−4−(トランス−アミノメチルシクロヘキサンカルボニル)アミノメチルシクロヘキサンカルボン酸、等〕、トラネキサム酸とハイドロキノンのエステル体〔例えば、トランス−4−アミノメチルシクロへキサンカルボン酸4’−ヒドロキシフェニルエステル、等〕、トラネキサム酸とゲンチシン酸のエステル体〔例えば、2−(トランス−4−アミノメチルシクロヘキシルカルボニルオキシ)−5−ヒドロキシ安息香酸およびその塩、等〕、トラネキサム酸のアミド体〔例えば、トランス−4−アミノメチルシクロヘキサンカルボン酸メチルアミドおよびその塩、トランス−4−(p−メトキシベンゾイル)アミノメチルシクロヘキサンカルボン酸およびその塩、トランス−4−グアニジノメチルシクロヘキサンカルボン酸およびその塩、等〕などが挙げられる。
【0019】
サリチル酸およびその誘導体としては、サリチル酸、3−メトキシサリチル酸およびその塩、4−メトキシサリチル酸およびその塩、5−メトキシサリチル酸およびその塩などが挙げられる。塩としてはナトリウム、カリウム、マグネシウム、トリエタノールアミンなどの各塩が例示される。
【0020】
レゾルシンおよびその誘導体としては、レゾルシン、4−n−ブチルレゾルシノールなどのアルキルレゾルシノール、およびこれらの塩などが挙げられる。塩としてはナトリウム、カリウム、マグネシウム、トリエタノールアミンなどの各塩が例示される。
【0021】
これらの美白剤を乳酸メンチルと組み合わせることにより、冷却感、美白剤の浸透感、美白効果感を飛躍的に高めることができる。
【0022】
これらの美白剤は、本発明皮膚外用剤中、0.001〜20質量%配合するのが好ましく、特には0.1〜10質量%である。0.001質量%未満では本願発明効果が十分に発揮され難く、一方、20質量%を超えて配合してもさほど大きな効果の向上は認められない。
【0023】
なお本発明において、乳酸メンチルの代わりに、他のメントール誘導体、例えばメチル o−アミノベンゾエート、メントキシプロパンジオール等を用いても、冷却感、冷却持続感、美白効果感等の点で劣り、本発明のような冷却感、冷却持続感、美白剤の浸透感、美白効果感の飛躍的な向上を得ることはできなかった。また冷却剤としてよく知られているメントール、カンファー、ミントなどを用いた場合も、特に冷却持続感、美白効果感の点で劣り、同様に本発明効果を得ることができなかった。
【0024】
本発明の皮膚外用剤は、上記必須成分以外に、本発明の効果を損わない範囲内で、通常化粧品や医薬品等の外用剤に用いられる成分、例えば、保湿剤、酸化防止剤、油性成分、紫外線吸収剤、界面活性剤、増粘剤、アルコール類、粉末成分、色剤、水性成分、水、各種皮膚栄養剤等を必要に応じて適宜配合することができる。
【0025】
さらに、エデト酸二ナトリウム、エデト酸三ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸等の金属封鎖剤、カフェイン、タンニン、ベラパミル、トラネキサム酸およびその誘導体、甘草抽出物、グラブリジン、カリンの果実の熱水抽出物、各種生薬、酢酸トコフェロール、グリチルリチン酸およびその誘導体またはその塩等の薬剤、グルコース、フルクトース、マンノース、ショ糖、トレハロース等の糖類、レチノイン酸、レチノール、酢酸レチノール、パルミチン酸レチノール等のビタミンA誘導体類なども適宜配合することができる。
【0026】
本発明は、その剤型が特に限定されるものでなく、溶液系、可溶化系、乳化系、粉末分散系、水−油二層系、水−油−粉末三層系、ジェル、エアゾール等、任意の剤型が適用される。
【0027】
またその使用形態も任意であり、例えば化粧水、乳液、クリーム、パック等のフェーシャル化粧料やファンデーションの他、メーキャップ化粧料、芳香化粧料、浴用剤等に用いることができるが、これら例示に限定されるものでないことはもちろんである。本発明では特に、不織布含浸化粧料(マスク)として用いた場合、冷却感、冷却持続感、美白剤の浸透感、美白効果感等の飛躍的向上をより効果的に感じることができ好ましい。なお、不織布含浸化粧料として用いる場合、グリセリン、1,3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、ポリプロピレングリコール(PPG)、ポリエチレングリコール(PEG)、ソルビトール、1,2−ペンタンジオール、ヘキシレングリコール等の多価アルコールや、水溶性高分子(ポリビニルアルコール、カルボキシビニルポリマー、ポリビニルピロリドン、ヒドロキシプロピルセルロース、メチルセルロースなど)を配合することにより、垂れ落ちを効果的に防止することができ、好ましい。
【0028】
【実施例】
次に、実施例によって本発明をさらに詳細に説明するが、本発明の技術的範囲はこれら実施例によってなんら限定されるものではない。なお、配合量は、特記しない限り質量%で示す。
【0029】
なお本実施例での評価試験は以下の方法に従った。
【0030】
[冷却感、冷却持続感]
専門パネル(女性20名)により、各試料(マスク)を肌に10分間貼付した後、剥がした。マスク貼付時の冷却感/剥がした後の冷却持続感について、下記評価基準に基づいて評価した。
(評価基準)
◎:冷却感に優れる(20名中16名以上が、マスク貼付時の冷却感/剥がした後の冷却持続感に優れると回答)
○:冷却感に優れる(20名中11〜15名が、マスク貼付時の冷却感/剥がした後の冷却持続感に優れると回答)
△:冷却感に優れる(20名中6〜10名が、マスク貼付時の冷却感/剥がした後の冷却持続感に優れると回答)
×:冷却感に優れる(20名中5名以下が、マスク貼付時の冷却感/剥がした後の冷却持続感に優れると回答)
【0031】
[美白剤の浸透感]
専門パネル(女性20名)により、各試料(マスク)を肌に10分間貼付した後、剥がした。マスク貼付時の美白剤の浸透感について、下記評価基準に基づいて評価した。
(評価基準)
◎:美白剤の浸透感に優れる(20名中16名以上が、マスク貼付時の美白剤の浸透感に優れると回答)
○:美白剤の浸透感に優れる(20名中11〜15名が、マスク貼付時の美白剤の浸透感に優れると回答)
△:美白剤の浸透感に優れる(20名中6〜10名が、マスク貼付時の美白剤の浸透感に優れると回答)
×:美白剤の浸透感に優れる(20名中5名以下が、マスク貼付時の美白剤の浸透感に優れると回答)
【0032】
[美白効果感]
専門パネル(女性20名)により、各試料(マスク)を肌に10分間貼付した後、剥がした。マスクを剥がした後の美白効果感について、下記評価基準に基づいて評価した。
(評価基準)
◎:美白効果感に優れる(20名中16名以上が、マスクを剥がした後の美白効果感に優れると回答)
○:美白効果感に優れる(20名中11〜15名が、マスクを剥がした後の美白効果感に優れると回答)
△:美白効果感に優れる(20名中6〜10名が、マスクを剥がした後の美白効果感に優れると回答)
×:美白効果感に優れる(20名中5名以下が、マスクを剥がした後の美白効果感に優れると回答)
【0033】
(実施例1〜7、比較例1〜9)
表1〜3に示すA相(アルコール相)をB相(水相)に添加し、可溶化して化粧水を調製した後、これを不織布に含浸させて、可溶化系美白ローション含浸シート状マスクを得た。このマスクを試料として、上記評価方法に従い、冷却感、冷却持続感、美白剤の浸透感、美白効果感について評価した。結果を表1〜3に示す。
【0034】
【表1】
【0035】
【表2】
【0036】
【表3】
【0037】
(実施例8)
(配 合 成 分) (質量%)
A相(アルコール相)
エタノール 10
PPG−13デシルテトラデセス−24 0.3
パラオキシ安息香酸メチル 0.1
フェノキシエタノール 0.1
香料 微量
乳酸メンチル 0.004
B相(水相)
グリセリン 2
PEG/PPG−14/7ジメチルエーテル 3
ジプロピレングリコール 1
1,3−ブチレングリコール 5
ジュウヤク抽出液 0.5
カリン抽出液 0.1
水酸化カリウム 適量
アスコルビン酸グルコシド 2
グリチルリチン酸ジカリウム 0.05
精製水 残余
(製法および評価)
A相(アルコール相)をB相(水相)に添加し、可溶化して化粧水を調製した後、これを不織布に含浸させて、可溶化系美白ローション含浸シート状マスクを得た。このマスクを試料として、上記評価方法に従い、冷却感、冷却持続感、美白剤の浸透感、美白効果感について評価したところ、いずれの項目においても良好な評価結果を得た。
【0038】
(実施例9)
(配 合 成 分) (質量%)
A相(アルコール相)
エタノール 5
PEG−60水添ヒマシ油 0.1
パラオキシ安息香酸メチル 0.15
香料 微量
乳酸メンチル 0.001
B相(水相)
PEG/PPG−9/2ジメチルエーテル 1
グリセリン 5
1,3−ブチレングリコール 5
カルボマー 0.15
ヒドロキシメチルセルロース 0.01
キサンタンガム 0.02
ルムプヤン抽出液 0.1
イザヨイバラ抽出液 0.3
アイリス抽出液 0.3
水酸化カリウム 適量
アスコルビン酸グルコシド 2
グリチルリチン酸ジカリウム 0.2
精製水 残余
(製法および評価)
A相(アルコール相)をB相(水相)に添加し、可溶化して化粧水を調製した後、これを不織布に含浸させて、可溶化系美白ローション含浸シート状マスクを得た。このマスクを試料として、上記評価方法に従い、冷却感、冷却持続感、美白剤の浸透感、美白効果感について評価したところ、いずれの項目においても良好な評価結果を得た。
【0039】
(実施例10)
(配 合 成 分) (質量%)
A相
ジイソステアリン酸ポリグリセリル 0.2
PEG−60水添ヒマシ油 0.2
トリ2−エチルヘキサン酸グリセリル 0.3
パラオキシ安息香酸メチル 0.17
香料 微量
乳酸メンチル 0.03
B相
グリセリン 3
1,3−ブチレングリコール 9.5
C相
ジュウヤク抽出液 0.3
水酸化カリウム 適量
アスコルビン酸グルコシド 2
グリチルリチン酸ジカリウム 0.05
オドリコソウエキス 0.1
ヨモギ抽出液 0.3
ハマメリエキス 0.1
カミツレ抽出液 0.5
精製水 残余
(製法および評価)
A相をB相と混合してから、C相(水相)に添加し、白濁系化粧水を調製した後、これを不織布に含浸させて、白濁系系美白美容液含浸シート状マスクを得た。このマスクを試料として、上記評価方法に従い、冷却感、冷却持続感、美白剤の浸透感、美白効果感について評価したところ、いずれの項目においても良好な評価結果を得た。
【0040】
(実施例11)
(配 合 成 分) (質量%)
A相(アルコール相)
エタノール 14
パラオキシ安息香酸メチル 0.1
フェノキシエタノール 0.2
香料 微量
乳酸メンチル 0.08
B相(水相)
グリセリン 3
ジプロピレングリコール 9.5
オウバクエキス 0.3
テンチャエキス 0.3
スルホ石炭酸ナトリウム 0.05
シャクヤクエキス 0.1
ローヤルゼリー 0.1
タイム抽出液 0.3
ボタンピ抽出液 0.1
水酸化カリウム 適量
アスコルビン酸グルコシド 2
グリチルリチン酸ジカリウム 0.1
ベントナイト 1
タルク 0.5
セルロース末 0.5
シリカ 0.3
酸化亜鉛 0.05
カオペーク 0.01
精製水 残余
(製法および評価)
A相(アルコール相)を、よく攪拌分散したB相(水相)に加え、攪拌混合して二層型化粧水を調製した後、これを不織布に含浸させて、二層型美白化粧水含浸シート状マスクを得た。このマスクを試料として、上記評価方法に従い、冷却感、冷却持続感、美白剤の浸透感、美白効果感について評価したところ、いずれの項目においても良好な評価結果を得た。
【0041】
(実施例12)
(配 合 成 分) (質量%)
A相(アルコール相)
エタノール 10
PPG−13デシルテトラデセス−24 0.3
パラオキシ安息香酸メチル 0.1
フェノキシエタノール 0.1
香料 微量
乳酸メンチル 0.004
B相(水相)
グリセリン 5
ジプロピレングリコール 1
カルボマー 0.01
PEG/PPG−36/41ジメチルエーテル 3
1,3ブチレングリコール 5
シャクヤク抽出液 0.5
ユキノシタ抽出液 0.1
ビワ葉エキス 0.1
アルブチン 7
グリチルリチン酸ジカリウム 0.1
精製水 残余
(製法および評価)
A相(アルコール相)をB相(水相)に添加し、可溶化して化粧水を調製した後、これを不織布に含浸させて、可溶化系美白ローション含浸シート状マスクを得た。このマスクを試料として、上記評価方法に従い、冷却感、冷却持続感、美白剤の浸透感、美白効果感について評価したところ、いずれの項目においても良好な評価結果を得た。
【0042】
【発明の効果】
以上詳述したように本発明の皮膚外用剤は、飛躍的に冷却感を高め、しかもその冷却感が持続し、かつ美白薬剤の浸透感、美白効果感等を飛躍的に高めることができた。[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to an external preparation for skin. More specifically, the present invention relates to an external preparation for skin which can dramatically increase the cooling feeling and maintain its effect, and has an extremely excellent effect of penetrating, whitening, and moisturizing agents (whitening agents). The present invention is particularly suitably used as a nonwoven fabric impregnated cosmetic (mask).
[0002]
[Prior art]
As the external preparation for skin, a menthol derivative (menthyl lactate, menthoxypropanediol, menthyl glucoside, etc.) having a slow-acting effect on the refreshing sensation is blended to provide a sustained refreshing sensation. However, menthol derivatives are less effective than conventional cooling agents such as menthol, camphor and the like in terms of refreshing effect, and are therefore used in combination with these conventional cooling agents or in combination with lower alcohols or silicone oils. Thus, a refreshing sensation and a lasting sensation are achieved (for example, see Patent Document 1).
[0003]
As described above, various skin external preparations containing a menthol derivative have been proposed, but none of the conventional preparations fall outside the concept of the sustainability of the refreshing sensation by the menthol derivative.
[0004]
[Patent Document 1]
JP 2001-226252 A [0005]
[Problems to be solved by the invention]
An object of the present invention is to provide a skin external preparation that dramatically enhances the cooling sensation, maintains the cooling sensation, and dramatically enhances the permeation of a whitening agent, the whitening effect, and the like.
[0006]
[Means for Solving the Problems]
The present invention for solving the above problems provides an external preparation for skin, comprising 0.0001 to 0.10% by mass of menthyl lactate and a whitening agent.
[0007]
Further, the present invention provides the whitening agent, wherein the hydroquinone glycoside and its derivative, L-ascorbic acid and its derivative, tranexamic acid and its derivative, salicylic acid and its derivative, resorcinol and its derivative, glutathione, kojic acid and ellagic acid are included. The above-mentioned external preparation for skin, which is one or more selected from the group consisting of:
[0008]
The present invention also provides the above-mentioned external preparation for skin, which is a nonwoven fabric-impregnated cosmetic (mask).
[0009]
BEST MODE FOR CARRYING OUT THE INVENTION
Hereinafter, the present invention will be described in detail.
[0010]
Menthyl lactate used in the present invention is a type of menthol derivative and is known as a slow-acting cooling agent. For example, it has been known that a menthol derivative is added to a formulation such as a lotion to maintain a refreshing sensation. However, by particularly selecting menthyl lactate among the menthol derivatives and combining and blending this menthyl lactate with a whitening agent, the cooling feeling can be dramatically improved, and the permeation and whitening effect of the whitening agent also increase dramatically. This finding was found by the present inventors for the first time, and is an effect unique to the present invention.
[0011]
The relationship between the cooling sensation / cooling sensation and the inflammation-suppressing effect is generally known as existing technology, but the causal relationship between the cooling sensation, the whitening sensation, and the whitening sensation is even confirmed by the effect. No information was obtained.
[0012]
In particular, when the present invention is used as a non-woven fabric impregnated cosmetic (mask), the mask is particularly suitable for cosmetics because of the characteristics of the product. The effect of "having" tends to be highly evaluated, so that the above effects obtained by the present invention are extremely excellent.
[0013]
In particular, in water-based cosmetics such as lotions and serums, a cooling sensation is felt by the heat of vaporization. When a water-based cosmetic such as such a lotion or a serum is used as a mask impregnated in a nonwoven fabric, there is an advantage that while the mask is stuck on the skin, the comfort due to the cooling feeling is felt. Until now, masks have only been characterized by a comfortable feeling due to the heat of vaporization during application. According to the present invention, a skin external preparation is not limited to a cooling sensation due to heat of vaporization, dramatically enhances a cooling sensation, further maintains the cooling sensation, and dramatically enhances a feeling of penetration of a whitening agent, a whitening effect, and the like. I got it.
[0014]
In order to achieve the effects of the present invention, menthyl lactate must be incorporated in the total amount of the external preparation for skin of the present invention in an amount of 0.0001 to 0.10% by mass, preferably 0.0005 to 0.10% by mass. . If the amount is less than 0.0001% by mass, a sufficient cooling feeling cannot be felt, while if it exceeds 0.10% by mass, the feeling of penetration of the whitening agent and the feeling of whitening effect tend to decrease.
[0015]
The whitening agent used in combination with the above-mentioned menthyl lactate is not particularly limited as long as it is a whitening agent that can be generally used in cosmetics. In the present invention, hydroquinone glycoside and its derivative, L-ascorbic acid and its derivative , Tranexamic acid and its derivatives, salicylic acid and its derivatives, resorcin and its derivatives, glutathione, kojic acid, ellagic acid and the like are preferably used.
[0016]
Examples of hydroquinone glycosides include hydroquinone α-D-glucose, hydroquinone β-D-glucose (also referred to as “arbutin”), hydroquinone α-L-glucose, hydroquinone β-L-glucose, hydroquinone α-D-galactose, Hexasaccharide glycosides such as hydroquinone β-D-galactose, hydroquinone α-L-galactose, hydroquinone β-L-galactose; hydroquinone α-D-ribose, hydroquinone β-D-ribose, hydroquinone α-L-ribose, Pentose sugar glycosides such as hydroquinone β-L-ribose, hydroquinone α-D-arabinose, hydroquinone β-D-arabinose, hydroquinone α-L-arabinose, hydroquinone β-L-arabinose; hydroquinone α-D-glucosami , Hydroquinone β-D-glucosamine, hydroquinone α-L-glucosamine, hydroquinone β-L-glucosamine, hydroquinone α-D-galactosamine, hydroquinone β-D-galactosamine, hydroquinone α-L-galactosamine, hydroquinone β-L-galactosamine. Aminosugar glycosides such as hydroquinone α-D-glucuronic acid, hydroquinone β-D-glucuronic acid, hydroquinone α-L-glucuronic acid, hydroquinone β-L-glucuronic acid, hydroquinone α-D-galacturonic acid, hydroquinone β And uronic acid carbohydrate glycosides such as -D-galacturonic acid, hydroquinone α-L-galacturonic acid, and hydroquinone β-L-galacturonic acid. Examples of the derivative include an ester such as an acetylated product and an ester such as a methylated product. Among them, ascorbic acid glucoside is preferred from the viewpoints of whitening effect, availability, and stability.
[0017]
L-ascorbic acid is generally referred to as vitamin C, and has a strong reductive action to have a cell respiratory action, an enzyme activating action, a collagen formation action, and a melanin reducing action. Examples of L-ascorbic acid derivatives include L-ascorbic acid monoesters such as L-ascorbic acid monophosphate and L-ascorbic acid 2-sulfate, and L-ascorbic acid glucoside such as L-ascorbic acid 2-glucoside. Or salts thereof, but are not limited to these examples. Examples of the salt include salts of sodium, potassium, magnesium, triethanolamine and the like.
[0018]
Examples of tranexamic acid and its derivatives include tranexamic acid, a dimer of tranexamic acid [eg, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.], an ester of tranexamic acid and hydroquinone [ For example, trans-4-aminomethylcyclohexanecarboxylic acid 4'-hydroxyphenyl ester, etc.], an ester of tranexamic acid and gentisic acid [eg, 2- (trans-4-aminomethylcyclohexylcarbonyloxy) -5- Hydroxybenzoic acid and its salts, etc.], amides of tranexamic acid [eg, trans-4-aminomethylcyclohexanecarboxylic acid methylamide and its salts, trans-4- (p-methoxybenzoyl) aminomethylcyclo Hexanecarboxylic acid and salts thereof, trans-4-guanidinomethylcyclohexanecarboxylic acid and salts thereof, and the like].
[0019]
Examples of salicylic acid and its derivatives include salicylic acid, 3-methoxysalicylic acid and its salts, 4-methoxysalicylic acid and its salts, and 5-methoxysalicylic acid and its salts. Examples of the salt include salts of sodium, potassium, magnesium, triethanolamine and the like.
[0020]
Examples of resorcinol and its derivatives include resorcinol, alkyl resorcinols such as 4-n-butyl resorcinol, and salts thereof. Examples of the salt include salts of sodium, potassium, magnesium, triethanolamine and the like.
[0021]
By combining these whitening agents with menthyl lactate, the cooling sensation, the permeation of the whitening agent, and the whitening effect can be dramatically improved.
[0022]
These whitening agents are preferably incorporated in the skin external preparation of the present invention in an amount of 0.001 to 20% by mass, particularly 0.1 to 10% by mass. If the amount is less than 0.001% by mass, the effect of the present invention is hardly sufficiently exerted. On the other hand, if the amount is more than 20% by mass, the effect is not so greatly improved.
[0023]
In the present invention, even if other menthol derivatives, for example, methyl o-aminobenzoate, menthoxypropanediol, etc. are used in place of menthyl lactate, they are inferior in cooling sensation, cooling sensation, whitening effect, etc. No dramatic improvement in cooling sensation, cooling sensation, permeation of whitening agent, and whitening effect as in the invention could be obtained. Also, when menthol, camphor, mint, etc., which are well-known as a cooling agent, are used, the cooling sustained feeling and the whitening effect feeling are particularly poor, and similarly, the effects of the present invention cannot be obtained.
[0024]
The skin external preparation of the present invention is, other than the above essential components, within the range not impairing the effects of the present invention, components usually used for external preparations such as cosmetics and pharmaceuticals, for example, humectants, antioxidants, oily components A UV absorber, a surfactant, a thickener, an alcohol, a powder component, a coloring agent, an aqueous component, water, various skin nutrition agents, and the like can be appropriately compounded as necessary.
[0025]
Further, sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, caffeine, tannin, verapamil, tranexamic acid and derivatives thereof, licorice extract, glabridine , Hot water extract of fruit of Karin, various crude drugs, drugs such as tocopherol acetate, glycyrrhizic acid and its derivatives or salts thereof, sugars such as glucose, fructose, mannose, sucrose, trehalose, retinoic acid, retinol, retinol acetate, Vitamin A derivatives such as retinol palmitate and the like can also be appropriately compounded.
[0026]
The present invention is not particularly limited in its dosage form, and includes a solution system, a solubilizing system, an emulsifying system, a powder dispersion system, a water-oil two-layer system, a water-oil-powder three-layer system, a gel, an aerosol, and the like. , Any dosage form is applied.
[0027]
The form of use is also optional. For example, in addition to facial cosmetics and foundations such as lotions, emulsions, creams, and packs, it can be used for makeup cosmetics, aromatic cosmetics, bath agents, and the like, but is not limited to these examples. Of course, it is not something that is done. In particular, in the present invention, when used as a nonwoven fabric impregnated cosmetic (mask), a drastic improvement in cooling sensation, cooling continuity, whitening agent permeation, whitening effect, and the like can be more effectively felt, which is preferable. When used as a nonwoven fabric impregnated cosmetic, glycerin, 1,3-butylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol (PPG), polyethylene glycol (PEG), sorbitol, 1,2-pentanediol, hexylene glycol By blending a polyhydric alcohol such as the above, or a water-soluble polymer (polyvinyl alcohol, carboxyvinyl polymer, polyvinylpyrrolidone, hydroxypropylcellulose, methylcellulose, etc.), dripping can be effectively prevented, which is preferable.
[0028]
【Example】
Next, the present invention will be described in more detail with reference to examples, but the technical scope of the present invention is not limited to these examples. In addition, the compounding amount is shown by mass% unless otherwise specified.
[0029]
The evaluation test in this example was performed according to the following method.
[0030]
[Cooling feeling, cooling lasting feeling]
Each sample (mask) was applied to the skin for 10 minutes by a specialized panel (20 women), and then peeled off. The cooling feeling at the time of sticking the mask / the cooling feeling after peeling was evaluated based on the following evaluation criteria.
(Evaluation criteria)
◎: Excellent cooling sensation (16 or more of the 20 respondents answered that the cooling sensation when applying the mask / the cooling continuity after peeling was excellent)
:: Excellent cooling sensation (11 to 15 out of 20 persons answered that the cooling sensation at the time of applying the mask / the cooling continuity after peeling was excellent)
Δ: Excellent cooling sensation (6 to 10 out of 20 respondents answered that cooling sensation at the time of mask attachment / cooling continuity after peeling was excellent)
×: Excellent cooling sensation (5/20 or less answered that cooling sensation at the time of mask attachment / cooling continuity after peeling was excellent)
[0031]
[Permeation of whitening agent]
Each sample (mask) was applied to the skin for 10 minutes by a specialized panel (20 women), and then peeled off. The permeation of the whitening agent when the mask was applied was evaluated based on the following evaluation criteria.
(Evaluation criteria)
◎: Excellent permeation of whitening agent (more than 16 out of 20 persons answered that permeation of whitening agent at the time of masking was excellent)
:: Excellent in feeling of penetration of whitening agent (11 to 15 out of 20 persons answered that the feeling of penetration of whitening agent when attaching a mask was excellent)
Δ: Excellent permeation of whitening agent (6 to 10 out of 20 respondents answered that permeation of whitening agent when applying mask was excellent)
×: Excellent permeation of whitening agent (5 or less out of 20 respondents answered that permeation of whitening agent at the time of mask attachment was excellent)
[0032]
[Whitening effect]
Each sample (mask) was applied to the skin for 10 minutes by a specialized panel (20 women), and then peeled off. The whitening effect after the mask was removed was evaluated based on the following evaluation criteria.
(Evaluation criteria)
◎: Excellent whitening effect (16 or more out of 20 persons answered that the whitening effect after removing the mask was excellent)
:: Excellent whitening effect (11 to 15 out of 20 persons answered that the whitening effect after removing the mask was excellent)
△: Excellent whitening effect (6 to 10 out of 20 persons answered that the whitening effect after removing the mask was excellent)
×: Excellent whitening effect (5 out of 20 persons answered that the whitening effect after removing the mask was excellent)
[0033]
(Examples 1 to 7, Comparative Examples 1 to 9)
A phase (alcohol phase) shown in Tables 1 to 3 is added to phase B (aqueous phase), solubilized to prepare a lotion, and then impregnated in a nonwoven fabric to form a solubilized whitening lotion impregnated sheet. I got a mask. Using this mask as a sample, the cooling sensation, the cooling sensation, the permeation of the whitening agent, and the whitening effect were evaluated according to the evaluation methods described above. The results are shown in Tables 1 to 3.
[0034]
[Table 1]
[0035]
[Table 2]
[0036]
[Table 3]
[0037]
(Example 8)
(Combined component) (% by mass)
Phase A (alcohol phase)
Ethanol 10
PPG-13 decyltetradeceth-24 0.3
Methyl paraoxybenzoate 0.1
Phenoxyethanol 0.1
Fragrance trace amount of menthyl lactate 0.004
Phase B (water phase)
Glycerin 2
PEG / PPG-14 / 7 dimethyl ether 3
Dipropylene glycol 1
1,3-butylene glycol 5
Jujuya extract 0.5
Karin extract 0.1
Potassium hydroxide suitable amount ascorbic acid glucoside 2
Dipotassium glycyrrhizinate 0.05
Purified water residue (production method and evaluation)
A phase (alcohol phase) was added to B phase (aqueous phase) and solubilized to prepare a lotion, which was then impregnated into a nonwoven fabric to obtain a solubilized whitening lotion-impregnated sheet mask. Using this mask as a sample, the cooling feeling, the cooling feeling, the permeation of the whitening agent, and the whitening effect were evaluated in accordance with the above-described evaluation methods. Good evaluation results were obtained in any of the items.
[0038]
(Example 9)
(Combined component) (% by mass)
Phase A (alcohol phase)
Ethanol 5
PEG-60 hydrogenated castor oil 0.1
Methyl paraoxybenzoate 0.15
Fragrance trace amount of menthyl lactate 0.001
Phase B (water phase)
PEG / PPG-9 / 2 dimethyl ether 1
Glycerin 5
1,3-butylene glycol 5
Carbomer 0.15
Hydroxymethylcellulose 0.01
Xanthan gum 0.02
Lumpuyan extract 0.1
Izayobara extract 0.3
Iris extract 0.3
Potassium hydroxide suitable amount ascorbic acid glucoside 2
Dipotassium glycyrrhizinate 0.2
Purified water residue (production method and evaluation)
A phase (alcohol phase) was added to B phase (aqueous phase) and solubilized to prepare a lotion, which was then impregnated into a nonwoven fabric to obtain a solubilized whitening lotion-impregnated sheet mask. Using this mask as a sample, the cooling feeling, the cooling feeling, the permeation of the whitening agent, and the whitening effect were evaluated in accordance with the above-described evaluation methods. Good evaluation results were obtained in any of the items.
[0039]
(Example 10)
(Combined component) (% by mass)
Phase A polyglyceryl diisostearate 0.2
PEG-60 hydrogenated castor oil 0.2
Glyceryl tri-2-ethylhexanoate 0.3
Methyl paraoxybenzoate 0.17
Fragrance trace amount of menthyl lactate 0.03
Phase B glycerin 3
1,3-butylene glycol 9.5
Phase C Jujube extract 0.3
Potassium hydroxide suitable amount ascorbic acid glucoside 2
Dipotassium glycyrrhizinate 0.05
Pompilot extract 0.1
Artemisia extract 0.3
Hamameli extract 0.1
Chamomile extract 0.5
Purified water residue (production method and evaluation)
After the phase A is mixed with the phase B and added to the phase C (aqueous phase) to prepare a cloudy lotion, the nonwoven fabric is impregnated with the same to obtain a sheet-like mask impregnated with a cloudy whitening beauty liquid. Was. Using this mask as a sample, the cooling feeling, the cooling feeling, the permeation of the whitening agent, and the whitening effect were evaluated in accordance with the above-described evaluation methods. Good evaluation results were obtained in any of the items.
[0040]
(Example 11)
(Combined component) (% by mass)
Phase A (alcohol phase)
Ethanol 14
Methyl paraoxybenzoate 0.1
Phenoxyethanol 0.2
Fragrance trace amount of menthyl lactate 0.08
Phase B (water phase)
Glycerin 3
Dipropylene glycol 9.5
Oak extract 0.3
Tencha extract 0.3
Sodium sulfocarbonate 0.05
Peony extract 0.1
Royal jelly 0.1
Thyme extract 0.3
Peanut extract 0.1
Potassium hydroxide suitable amount ascorbic acid glucoside 2
Dipotassium glycyrrhizinate 0.1
Bentonite 1
Talc 0.5
Cellulose powder 0.5
Silica 0.3
Zinc oxide 0.05
Khao Paek 0.01
Purified water residue (production method and evaluation)
A phase (alcohol phase) is added to B phase (aqueous phase) which is well stirred and dispersed, stirred and mixed to prepare a two-layer type lotion, which is impregnated into a non-woven fabric to impregnate the two-layer type whitening lotion. A sheet mask was obtained. Using this mask as a sample, the cooling sensation, the cooling continuity, the permeation of the whitening agent, and the whitening effect were evaluated in accordance with the above evaluation methods. Good evaluation results were obtained in any of the items.
[0041]
(Example 12)
(Combined component) (% by mass)
Phase A (alcohol phase)
Ethanol 10
PPG-13 decyltetradeceth-24 0.3
Methyl paraoxybenzoate 0.1
Phenoxyethanol 0.1
Fragrance trace amount of menthyl lactate 0.004
Phase B (water phase)
Glycerin 5
Dipropylene glycol 1
Carbomer 0.01
PEG / PPG-36 / 41 dimethyl ether 3
1,3 butylene glycol 5
Peony extract 0.5
Saxifraga extract 0.1
Loquat leaf extract 0.1
Arbutin 7
Dipotassium glycyrrhizinate 0.1
Purified water residue (production method and evaluation)
A phase (alcohol phase) was added to B phase (aqueous phase) and solubilized to prepare a lotion, which was then impregnated into a nonwoven fabric to obtain a solubilized whitening lotion-impregnated sheet mask. Using this mask as a sample, the cooling sensation, the cooling continuity, the permeation of the whitening agent, and the whitening effect were evaluated in accordance with the above evaluation methods. Good evaluation results were obtained in any of the items.
[0042]
【The invention's effect】
As described in detail above, the external preparation for skin of the present invention drastically increased the cooling feeling, the cooling feeling was sustained, and the feeling of penetration of the whitening agent, the feeling of whitening effect, etc. could be drastically increased. .
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002294467A JP2004131388A (en) | 2002-10-08 | 2002-10-08 | Skin care preparation for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002294467A JP2004131388A (en) | 2002-10-08 | 2002-10-08 | Skin care preparation for external use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2004131388A true JP2004131388A (en) | 2004-04-30 |
Family
ID=32284999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002294467A Pending JP2004131388A (en) | 2002-10-08 | 2002-10-08 | Skin care preparation for external use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004131388A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008505470A (en) * | 2004-07-05 | 2008-02-21 | シーイービーティー・カンパニー・リミティッド | Control method of electron beam in multi-microcolumn and multi-microcolumn using this method |
| JP2008184443A (en) * | 2007-01-31 | 2008-08-14 | Taisho Pharmaceutical Co Ltd | Adapalene-containing external preparation composition |
| JP2009023947A (en) * | 2007-07-19 | 2009-02-05 | Kuraray Co Ltd | Topical skin preparation |
| JP5244400B2 (en) * | 2005-12-26 | 2013-07-24 | 株式会社林原 | Alkylresorcinol glycoside, its production method and use |
| WO2013151042A1 (en) * | 2012-04-02 | 2013-10-10 | 高砂香料工業株式会社 | Melanin production inhibitor |
| JP2016088882A (en) * | 2014-11-04 | 2016-05-23 | ロート製薬株式会社 | External preparation |
| KR20210088049A (en) * | 2020-01-03 | 2021-07-14 | 구본철 | Skin-whitening mask, skin-whitening device and skin-whitening method using the same |
-
2002
- 2002-10-08 JP JP2002294467A patent/JP2004131388A/en active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008505470A (en) * | 2004-07-05 | 2008-02-21 | シーイービーティー・カンパニー・リミティッド | Control method of electron beam in multi-microcolumn and multi-microcolumn using this method |
| JP5244400B2 (en) * | 2005-12-26 | 2013-07-24 | 株式会社林原 | Alkylresorcinol glycoside, its production method and use |
| JP2008184443A (en) * | 2007-01-31 | 2008-08-14 | Taisho Pharmaceutical Co Ltd | Adapalene-containing external preparation composition |
| JP2009023947A (en) * | 2007-07-19 | 2009-02-05 | Kuraray Co Ltd | Topical skin preparation |
| WO2013151042A1 (en) * | 2012-04-02 | 2013-10-10 | 高砂香料工業株式会社 | Melanin production inhibitor |
| JP2013213003A (en) * | 2012-04-02 | 2013-10-17 | Takasago Internatl Corp | Melanin production inhibitor |
| JP2016088882A (en) * | 2014-11-04 | 2016-05-23 | ロート製薬株式会社 | External preparation |
| KR20210088049A (en) * | 2020-01-03 | 2021-07-14 | 구본철 | Skin-whitening mask, skin-whitening device and skin-whitening method using the same |
| KR102352140B1 (en) * | 2020-01-03 | 2022-01-17 | 구본철 | Skin-whitening mask, skin-whitening device and skin-whitening method using the same |
| KR20220010050A (en) * | 2020-01-03 | 2022-01-25 | 구본철 | Skin-whitening mask, skin-whitening device and skin-whitening method using the same |
| KR102624487B1 (en) * | 2020-01-03 | 2024-01-11 | 구본철 | Skin-whitening mask, skin-whitening device and skin-whitening method using the same |
| KR20240010069A (en) * | 2020-01-03 | 2024-01-23 | 구본철 | Skin-whitening mask, skin-whitening device and skin-whitening method using the same |
| KR102852824B1 (en) | 2020-01-03 | 2025-09-03 | 주식회사 스킨십 | Skin-whitening mask, skin-whitening device and skin-whitening method using the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8945523B2 (en) | Skin lightening composition for hyperpigmented skin | |
| EP1806120B1 (en) | Composition for prevention or alleviation of pigmentation | |
| CN105030565A (en) | Whitening agent for topical application, and process for whitening skin | |
| JP2008007432A (en) | Topical skin preparation | |
| JP2937446B2 (en) | Blackening agent to prevent gray hair | |
| JP4667336B2 (en) | Skin preparation | |
| JP6194165B2 (en) | Topical skin preparation | |
| JP4518367B2 (en) | Pore reducing agent | |
| JP2005120023A (en) | Skin care preparation | |
| JP2008273851A (en) | Skin preparation | |
| JPH11246339A (en) | Preparation for external use for skin | |
| JP3271840B2 (en) | Novel isoflavone glycosides and cosmetics containing the same | |
| JP2003306419A (en) | Cosmetic | |
| JP2004131388A (en) | Skin care preparation for external use | |
| SG187424A1 (en) | Composition for external application | |
| JP3730102B2 (en) | Skin preparation for penetration enhancement | |
| WO2019151275A1 (en) | Method for improving stickiness of adenosine-phosphate-containing composition | |
| JPH0533683B2 (en) | ||
| JP2004115381A (en) | External preparation for skin | |
| JPH1036246A (en) | Suppressant for melanogenesis and preparation for external use for skin | |
| JP3763810B2 (en) | Topical skin preparation | |
| JP2001288045A (en) | Composition for scalp and hair | |
| JP2002234828A (en) | Skin whitening cosmetic preparation | |
| EP4327802A1 (en) | Cosmetic | |
| JP5856761B2 (en) | External preparation for skin and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Effective date: 20050518 Free format text: JAPANESE INTERMEDIATE CODE: A621 |
|
| A977 | Report on retrieval |
Effective date: 20060516 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20060601 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A02 | Decision of refusal |
Effective date: 20080207 Free format text: JAPANESE INTERMEDIATE CODE: A02 |